NARDINI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 8.275
EU - Europa 4.773
AS - Asia 3.839
SA - Sud America 480
Continente sconosciuto - Info sul continente non disponibili 136
AF - Africa 69
OC - Oceania 4
Totale 17.576
Nazione #
US - Stati Uniti d'America 8.044
IT - Italia 1.907
GB - Regno Unito 1.130
CN - Cina 1.122
SG - Singapore 1.081
SE - Svezia 451
HK - Hong Kong 383
BR - Brasile 367
VN - Vietnam 345
DE - Germania 298
BD - Bangladesh 231
TR - Turchia 229
UA - Ucraina 188
FI - Finlandia 179
FR - Francia 156
CA - Canada 125
RU - Federazione Russa 125
KR - Corea 119
IN - India 99
NL - Olanda 70
BG - Bulgaria 64
AR - Argentina 45
MX - Messico 45
ID - Indonesia 34
PL - Polonia 28
IQ - Iraq 27
IE - Irlanda 25
ES - Italia 23
IR - Iran 22
LT - Lituania 20
CO - Colombia 18
IL - Israele 18
PK - Pakistan 18
BE - Belgio 17
CR - Costa Rica 17
ZA - Sudafrica 17
JM - Giamaica 16
JP - Giappone 15
SA - Arabia Saudita 15
CH - Svizzera 14
AT - Austria 13
AE - Emirati Arabi Uniti 12
EU - Europa 12
EC - Ecuador 11
SI - Slovenia 11
CL - Cile 10
MA - Marocco 10
EG - Egitto 9
MY - Malesia 9
TH - Thailandia 9
VE - Venezuela 9
DZ - Algeria 8
JO - Giordania 7
PY - Paraguay 7
UZ - Uzbekistan 7
BY - Bielorussia 6
DK - Danimarca 6
CZ - Repubblica Ceca 5
GR - Grecia 5
GT - Guatemala 5
KE - Kenya 5
PE - Perù 5
PH - Filippine 5
RS - Serbia 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
EE - Estonia 4
HN - Honduras 4
KZ - Kazakistan 4
NI - Nicaragua 4
PA - Panama 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
AL - Albania 3
AU - Australia 3
BO - Bolivia 3
ET - Etiopia 3
GE - Georgia 3
LB - Libano 3
NG - Nigeria 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CU - Cuba 2
CY - Cipro 2
KG - Kirghizistan 2
LV - Lettonia 2
MG - Madagascar 2
MK - Macedonia 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
QA - Qatar 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
Totale 17.437
Città #
Ashburn 1.074
Santa Clara 843
Southend 832
Singapore 730
Woodbridge 496
Fairfield 433
Chandler 429
San Jose 383
Hong Kong 374
Jacksonville 355
Hefei 332
Houston 268
Ann Arbor 260
Beijing 246
Nyköping 246
Dearborn 234
Wilmington 200
Milan 185
Seattle 178
Council Bluffs 172
Rome 165
London 159
Dallas 151
Cambridge 150
Los Angeles 131
Izmir 120
Seoul 117
Helsinki 114
New York 102
Buffalo 89
Ho Chi Minh City 89
The Dalles 87
São Paulo 85
Hanoi 77
Naples 76
Princeton 70
San Diego 64
Chicago 62
Sofia 62
Eugene 61
Frankfurt am Main 57
Modena 57
Lauterbourg 54
Shanghai 51
Toronto 48
Des Moines 39
Moscow 37
Bari 36
Bologna 36
Munich 36
Florence 33
Palermo 33
Atlanta 28
Philadelphia 26
Columbus 25
Orem 25
Da Nang 24
Turin 24
Brescia 23
Chennai 23
Guangzhou 21
Catania 20
Dublin 20
Montreal 19
Mexico City 18
Phoenix 17
Boardman 16
Brooklyn 16
Brussels 16
Elk Grove Village 16
Haiphong 16
Redwood City 16
Salt Lake City 16
Memphis 15
San Mateo 15
Augusta 14
Ottawa 14
Vancouver 14
Warsaw 14
Amsterdam 13
Baghdad 13
Falkenstein 13
Jakarta 13
Mumbai 13
Norwalk 13
Rio de Janeiro 13
Stockholm 13
Kent 12
Manassas 12
Nanjing 12
Tampa 12
Denver 11
Genoa 11
Parma 11
San José 11
Tokyo 11
Falls Church 10
Johannesburg 10
Kunming 10
Mashhad 10
Totale 11.576
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.943
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 377
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: A long follow-up experience 366
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients 364
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 325
Long-term psychometric outcomes of facial lipoatrophy therapy: Forty-eight-week observational, nonrandomized study 325
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 321
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 318
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 314
Effectiveness and durability of polyacrylamide hydrogel injections for treating HIV-related facial lipoatrophy 313
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 309
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 308
Detectable HIV viral load is associated with metabolic syndrome 306
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: 1-year follow-up 300
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens. 300
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 299
Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: Monarch randomized controlled trial 298
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 286
Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection 285
Severity of lipodystrophy is associated with decreased health-related quality of life 283
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 281
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 267
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 267
Monitoraggio di infezione da Citomegalovirus (CMV)nel paziente sottoposto a trapianto di intestino 264
Age-related comorbidities in people living with HIV 262
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV 261
Effectiveness and long-term durability of autologous fat transplant for HIV-related face lipoatrophy. 257
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 247
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 242
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 241
Prevalence and risk factors of pubic lipomas in HIV-infected patients 239
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation 238
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 237
Does lipodistrophy affect quality of life? 237
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 236
How do frailty mediate pathway leading to disability 236
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 235
Virologic failure and metabolic syndrome in patients with HIV infection 234
Body Image perception in HIV infected women with body fat redistribution. 232
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 223
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 222
Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the italian version of assessment of body change and distress questionnaire 218
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 217
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 213
È possibile un counselling HIV su internet? 211
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 209
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation 209
Validity of body image perception in women with HIV. 201
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial 199
Pregnancy outcomes and cytomegalovirus DNAemia in HIV-infected pregnant women with CMV 197
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 195
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 193
Virologic failure and metabolic syndrome in patients with HIV infection 193
Relapse of HIV-related buffalo hump after liposuction 190
Lipodystrophy and quality of life: a prospective study 188
Ruolo della chirurgia plastica nel trattamento della sindrome da ridistribuzione del tessuto adiposo 183
Prospective, 48 weeks follow up, multidisciplinary interventionalstudy to assess improvement of adherence in people with lipodistrophy. 182
Qual è il rapporto tra qualità di vita e lipodistrofia 181
HIV counselling looks for new target and methods web versus face to face counselling 173
Metabolic and anthropometric alterations in a population of HIV infected patients with a high prevalence of lipodystrophy: associations with HCV coinfection 172
Nuovi obiettivi e strumenti di lavoro nel counselling HIV: studio prospettico osservazionale del counselling informatico versus il counselling vis a vis 157
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 152
Lipodistrophy is related to adherence to antiretroviral therapy (ARV) 152
Gender differences in depression evolution in a cohort of patients attendine a metabolic clinic for lipodystrophy management 152
HIV counselling and prevention on the WEB 141
Totale 17.576
Categoria #
all - tutte 58.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022745 0 0 0 98 29 51 41 75 104 78 149 120
2022/20231.483 150 127 119 114 129 204 38 156 195 45 111 95
2023/20241.036 64 72 79 129 149 81 97 106 36 50 57 116
2024/20252.944 117 69 73 227 624 427 221 127 337 97 294 331
2025/20265.021 335 235 509 561 579 402 507 273 544 428 360 288
2026/20271.490 174 326 543 447 0 0 0 0 0 0 0 0
Totale 17.576